The predictive value of C-reactive protein combined with platelets for the progression and prognosis of sepsis: A retrospective cohort study

Abstract

This retrospective cohort study aimed to explore the predictive value of the C-reactive protein (CRP)/platelet count (PLT) ratio for sepsis progression and prognosis. A total of 237 sepsis patients admitted to the ICU between January 2019 and November 2024 were divided into survivor (n = 157) and non-survivor (n = 80) groups based on 28-day outcomes. Intergroup comparison, receiver operating characteristic (ROC) curve analysis, survival analysis, LASSO regression analysis, and Cox regression analysis were employed to evaluate the impact of clinical data, dynamic CRP/PLT ratios (on days 1 and 7), and change degree ((CRP/PLT day 7 − CRP/PLT day 1)/CRP/PLT day 1) on the progression and prognosis of sepsis. The non-survivor group showed significantly higher CRP/PLT ratios on day 1 (0.80 vs 0.39, p < 0.001), day 7 (1.40 vs 0.29, p < 0.001), and change degree (0.44 vs −0.31, p < 0.001) compared to the survivor group. Time-dependent ROC analysis revealed the CRP/PLT ratio on day 7 had the highest prognostic accuracy for short-term mortality (AUC = 0.819). After LASSO selection and multivariable adjustment, CRP/PLT ratio on day 7 > 0.51 (HR = 2.21, 95% CI: 1.17, 4.15) and change degree > −0.04 (HR = 1.89, 95% CI: 1.06, 3.38) remained significant prognostic factors for mortality. These findings suggest the CRP/PLT ratio, particularly on day 7, and the change degree can serve as effective indicators for the early assessment of mortality risk in sepsis patients, aiding clinical prognosis and treatment adjustment.

Keywords

sepsis C-reactive protein platelet count mortality prediction

Get full access to this article

View all access options for this article.

References

Singer

Deutschman

Seymour

, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315(8): 801–810.

Rudd

Johnson

Agesa

, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 2020; 395(10219): 200–211.

Fleischmann

Scherag

Adhikari

, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med 2016; 193(3): 259–272.

Pan

Xie

Zhang

, et al. Evaluate prognostic accuracy of SOFA component score for mortality among adults with sepsis by machine learning method. BMC Infect Dis 2023; 23(1): 76.

Fleuren

Klausch

TLT

Zwager

, et al. Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy. Intensive Care Med 2020; 46(3): 383–400.

Serhan

Savill

Resolution of inflammation: the beginning programs the end. Nat Immunol 2005; 6(12): 1191–1197.

Tracey

KJ.

The inflammatory reflex. Nature 2002; 420(6917): 853–859.

Faix

JD.

Biomarkers of sepsis. Crit Rev Clin Lab Sci 2013; 50(1): 23–36.

van der Poll

van de Veerdonk

Scicluna

, et al. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol 2017; 17(7): 407–420.

10.

Deppermann

Kubes

Platelets and infection. Semin Immunol 2016; 28(6): 536–545.

11.

Vincent

Yagushi

Pradier

Platelet function in sepsis. Crit Care Med 2002; 30(5 Suppl.): S313–S317.

12.

Larkin

Santos-Martinez

Ryan

, et al. Sepsis-associated thrombocytopenia. Thromb Res 2016; 141: 11–16.

13.

Aydemir

Piskin

Akduman

, et al. Platelet and mean platelet volume kinetics in adult patients with sepsis. Platelets 2015; 26(4): 331–335.

14.

Dwivedi

AK.

How to write statistical analysis section in medical research. J Investig Med 2022; 70(8): 1759–1770.

15.

Liu

Yao

, et al. Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis. BMC Infect Dis 2022; 22(1): 564.

16.

Kim

Lim

, et al. Sepsis alert systems, mortality, and adherence in emergency departments: a systematic review and meta-analysis. JAMA Netw Open 2024; 7(7): e2422823.

17.

Yan

Chen

Quan

, et al. Association between the stress hyperglycemia ratio and 28-day all-cause mortality in critically ill patients with sepsis: a retrospective cohort study and predictive model establishment based on machine learning. Cardiovasc Diabetol 2024; 23(1): 163.

18.

Hernández

Ospina-Tascón

Damiani

, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: The ANDROMEDA-SHOCK randomized clinical trial. JAMA 2019; 321(7): 654–664.

19.

Huang

, et al. Risk factors and a prediction model for sepsis: a multicenter retrospective study in China. J Intensive Med 2022; 2(3): 183–188.

20.

Cheng

Pan

Fang

, et al. Association of cancers with the occurrence and 28-day mortality of sepsis: a Mendelian randomization and mediator analysis. Sci Rep 2025; 15(1): 5600.

21.

Cecconi

Evans

Levy

, et al. Sepsis and septic shock. Lancet 2018; 392(10141): 75–87.

22.

Bhattacharya

Munshi

Biological significance of C-reactive protein, the ancient acute phase functionary. Front Immunol 2023; 14: 1238411.

23.

Kushner

C-reactive protein – My perspective on its first half century, 1930-1982. Front Immunol 2023; 14: 1150103.

24.

Pierrakos

Velissaris

Bisdorff

, et al. Biomarkers of sepsis: time for a reappraisal. Crit Care 2020; 24(1): 287.

25.

Yue

Dong

, et al. Sepsis biomarkers: advancements and clinical applications-A narrative review. Int J Mol Sci 2024; 25(16): 9010.

26.

Tan

Jiang

, et al. The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: a systematic review and meta-analysis. J Cell Biochem 2019; 120(4): 5852–5859.

27.

Reddy

Wante

Nirhale

, et al. The prospective analysis of biomarkers in sepsis: correlation with clinical outcomes. Cureus 2024; 16(10): e70965.

28.

Windgassen

Funtowicz

Lunsford

, et al. C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians. Postgrad Med 2011; 123(1): 114–119.

29.

Ridker

Rifai

Rose

, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347(20): 1557–1565.

30.

Goldberg

Shalmon

Shteinvil

, et al. The superiority of 72 h leukocyte descent over CRP for mortality prediction in patients with sepsis. Clin Chim Acta 2021; 514: 34–39.

31.

Martin-Loeches

Singer

Leone

Sepsis: key insights, future directions, and immediate goals. A review and expert opinion. Intensive Care Med 2024; 50(12): 2043–2049.

32.

Wang

, et al. Clinical value of C-Reactive protein/platelet ratio in neonatal sepsis: a cross-sectional study. J Inflamm Res 2021; 14: 5123–5129.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.02 MB

0.00 MB